[1]王秀莹,赵长松,张文龙.健脾泄浊解毒方治疗糖尿病肾病临床研究[J].陕西中医,2025,46(1):68-71.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.014]
　WANG Xiuying,ZHAO Changsong,ZHANG Wenlong.Clinical study on the treatment of diabetic nephropathy with Jianpi Xiezhuo Jiedu prescription[J].,2025,46(1):68-71.[doi:DOI:10.3969/j.issn.1000-7369.2025.01.014]
点击复制

健脾泄浊解毒方治疗糖尿病肾病临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年1期
页码:
68-71
栏目:
临床研究
出版日期:
2025-01-05

文章信息/Info

Title:
Clinical study on the treatment of diabetic nephropathy with Jianpi Xiezhuo Jiedu prescription
作者:
王秀莹; 赵长松; 张文龙
(唐山市中医医院,河北 唐山 063000)
Author(s):
WANG Xiuying; ZHAO Changsong; ZHANG Wenlong
(Tangshan Hospital of Traditional Chinese Medicine,Tangshan 063000,China)
关键词:
糖尿病肾病;  健脾泄浊解毒方;  肠道菌群;  氧化因子;  免疫因子;  肾功能
Keywords:
Diabetic nephropathy;  Jianpi Xiezhuo Jiedu prescription;  Intestinal flora;  Oxidation factor;  Immune factor;  Renal function
分类号:
R 587.2
DOI:
DOI:10.3969/j.issn.1000-7369.2025.01.014
文献标志码:
A
摘要:
目的:观察健脾泄浊解毒方对糖尿病肾病(DN)患者炎症因子、氧化因子、血糖、肾功能、肠道菌群等指标的影响。方法:采用随机数字法将100例DN患者平均分为对照组和观察组各50例,对照组给予常规疗法治疗,观察组给予健脾泄浊解毒方治疗,比较治疗前后两组患者炎症因子(CRP、TNF-α、IL-6)、血糖(PBG、FBG、HbA1c)、肾功能(UALB、BUN、eGFR)、氧化因子(SOD、MDA、TAOC)、免疫因子(CD3+、CD4+、CD4+/CD8+)及肠道菌群(双歧杆菌、乳酸杆菌、拟杆菌、肠球菌、大肠杆菌)的变化。结果:治疗后,观察组患者CRP、TNF-α、IL-6、MDA、CD8+、PBG、FBG、HbA1c水平及肠球菌数目均显著降低,且观察组各水平均显著低于对照组; 而两组患者SOD、TAOC、CD3+、CD4+、CD4+/CD8+比值、eGFR及有益菌群的数量均升高,且观察组的SOD、TAOC、CD3+、CD4+、CD4+/CD8+比值、eGFR及有益菌群的数值均比对照组显著升高(P<0.05)。结论:健脾泄浊解毒方治疗糖尿病肾病可显著减轻炎症反应,提升免疫功能,改善患者血糖水平、氧化因子水平和肾功能指标,且利于机体肠道有益菌群的增加,疗效显著。
Abstract:
Objective:To observe the effects of Jianpi Xiezhuo Jiedu prescription on inflammatory factors,oxidation factors,blood glucose,renal function,intestinal flora and other indexes in diabetic nephropathy(DN)patients.Methods:A total of 100 diabetic nephropathy patients were included,and their scores were divided into two groups by random number method.The control group was treated with conventional therapy,and the observation group was treated with Jianpi Xiuzhu Jiedu prescription.Inflammatory factors(CRP,TNF-α,IL-6),blood glucose(PBG,FBG,HbA1c),renal function(UALB,BUN,eGFR),oxidation factors(SOD,MDA,TAOC),immune factors(CD3+,CD4+,CD4+/CD8+)and intestinal flora(bifidum)were compared between the two groups before and after treatment(Bacillus,Lactobacillus,Bacteroides,Enterococcus,Escherichia coli).Results:After treatment,the levels of CRP,TNF-α,IL-6,MDA,CD8+,PBG,FBG,HbA1c and enterococcus in observation group were significantly decreased,and the levels found in the observation group were considerably lower than the ones in the control group.SOD,TAOC,CD3+,CD4+,CD4+/CD8+ ratio,eGFR and the number of bifidobacterium,Moreover,SOD,TAOC,CD3+,CD4+,CD4+/CD8+ ratio,eGFR and beneficial bacteria in observation group were significantly higher than those in control group(P<0.05).Conclusion:Jianpi Xiezhuo Jiedu prescription in the treatment of diabetic nephropathy can not only significantly reduce the body inflammatory response of patients,enhance the immune level,but also help to improve the blood sugar level,oxidation factor level and renal function index of patients,and at the same time,it is conducive to the increase of beneficial bacteria in the intestinal tract of the body,with significant curative effect.

参考文献/References:

[1] 李慧灵,张建德,叶静,等.加味玉液汤治疗气阴两虚型糖尿病肾病慢性肾衰竭疗效及对患者微炎症状态的影响[J].陕西中医,2022,43(8):1064-1067.
[2] 屈雅娟,张敬芳,孙旗,等.灯盏细辛联合依帕司他对糖尿病肾病模型大鼠的治疗作用及机制[J].陕西中医,2022,43(10):1337-1341.
[3] 邢增辉,张一绚,韩冰,等.黄葵胶囊治疗IgA肾病、糖尿病肾病及膜性肾病疗效比较[J].中国中西医结合肾病杂志,2023,24(3):207-212.
[4] 宇汝翠,陆智慧,李金虎,等.益气养阴通络方通过lncRNA UCA1靶向调控miR-485-5p抑制糖尿病肾病大鼠肾小管上皮细胞凋亡及炎症反应作用机制[J].陕西中医,2023,44(8):1000-1004.
[5] 阮诺冰,李金菊,林逸轩,等.苁归益肾胶囊对糖尿病肾病大鼠肾纤维化及MEK/ERK信号通路的影响[J].陕西中医,2023,44(2):139-143.
[6] 张倩,赵霞,王峥.积芎解毒方联合西药对糖尿病肾病的降糖效果及调节微炎症状态的作用[J].中国卫生检验杂志,2023,33(5):576-579.
[7] 李凡,王杰,崔成姬,等.基于“脾病下流乘肾”探讨糖尿病肾病研究进展[J].陕西中医,2023,44(12):1823-1826.
[8] 孙晓红,钟梦丹,庄琪,等.益气养阴活血方联合中药熏洗治疗糖尿病肾病[J].长春中医药大学学报,2023,39(12):1351-1355.
[9] 刘彤崴,高丽利,蔡宏宇,等.长链非编码RNA牛磺酸上调基因1在糖尿病肾病中的表达及意义[J].陕西医学杂志,2023,52(3):340-343.
[10] 赵莉,马居里,王惠玲,等.益肾泄浊法治疗糖尿病肾病肾损伤临床疗效的系统评价[J].中国中西医结合肾病杂志,2023,24(6):513-517.
[11] 李红霞,魏田静,刘晓宇,等.温脾补肾泄浊汤联合厄贝沙坦治疗糖尿病肾病的疗效[J].实用心脑肺血管病杂志,2022,30(8):91-95.
[12] 邓林,王少清,李萃萃,等.蛋白质组学在糖尿病肾病诊断及治疗中的应用研究进展[J].保健医学研究与实践,2022,19(9):171-176.
[13] 蒋琳,陆璧,张彦,等.血管生成抑制蛋白1、血清沉默信息调节因子1、血栓素-B2在2型糖尿病肾病中的水平变化及与白蛋白尿进展的关系分析[J].陕西医学杂志,2024,53(1):46-50.
[14] 李春梦,王海峰,卢佩,等.糖尿病肾病患者D-二聚体、纤维蛋白原、胱抑素C检测及临床意义[J].陕西医学杂志,2020,49(11):1503-1506.
[15] 王丽莉,王琛.从“玄府”理论探讨风药辨治糖尿病肾病蛋白尿[J].辽宁中医杂志,2023,50(9):48-50.
[16] 蔡小凡,黄洁波,邢玥,等.益肾化湿颗粒对糖尿病肾病小鼠中Yes相关蛋白的调控作用[J].中国药理学通报,2023,39(10):1944-1949.
[17] 邓媛媛,马钰,李娜,等.张勉之教授基于“补肾活血”思想治疗糖尿病肾病的经验撷英[J].中国中西医结合肾病杂志,2023,24(9):765-767.
[18] 郭帅,白璐,潘利敏,等.补阳还五汤合参芪地黄汤化裁对糖尿病肾病小鼠肾小管间质纤维化的作用及机制研究[J].中草药,2022,53(2):470-477.
[19] 王永军,张云,石良静,等.百令胶囊联合前列地尔对糖尿病肾病患者炎症因子及肝肾功能的影响[J].西部中医药,2022,35(6):115-117.
[20] 栗红星,袁芮芮,赵芳.卡格列净联合厄贝沙坦对早期糖尿病肾病患者肾功能及炎症因子的影响[J].中国医师杂志,2024,26(5):748-751.
[21] 屈雅娟,张敬芳,孙旗,等.灯盏细辛联合依帕司他对糖尿病肾病大鼠肾皮质中CAT、SOD、MDA表达的影响[J].中医药信息,2023,40(10):41-45.
[22] 王萍,王文娟,杜翔.慢性肾脏病患者肾素-血管紧张素系统与血浆β-淀粉样蛋白相关性研究[J].陕西医学杂志,2022,51(5):547-577,590.
[23] 吴雅茹,魏凯悦,王彩丽.肠道菌群失衡与肠道屏障损伤在糖尿病肾脏疾病中的研究进展[J].肾脏病与透析肾移植杂志,2023,32(5):477-480.
[24] 石艳红,邵英.生物钟相关基因CLOCK及褪黑素受体MT1和MT2基因与2型糖尿病患者肠道菌群及炎症因子相关性分析[J].陕西医学杂志,2023,52(3):335-339.
[25] 贾燚鑫,宋志慧,高春燕,等.麦冬多糖调控胰高血糖素样肽-1对妊娠期糖尿病大鼠肠道菌群及糖代谢的影响[J].陕西中医,2023,44(4):427-432.

相似文献/References:

[1]张华贞.复方黄芪汤加减联合骨化三醇治疗糖尿病肾病疗效及对患者血糖、肾功的影响*[J].陕西中医,2019,(6):767.
[2]程红卫,成晓萍.阎晓萍从脾论治糖尿病肾病经验总结*[J].陕西中医,2019,(6):790.
[3]黄聪丽,王治新△.益气滋肾活血通络方治疗早中期糖尿病肾病临床研究[J].陕西中医,2019,(10):1390.
　HUANG Congli,WANG Zhixin..Clinical efficacy analysis of Yiqi Zishen Huoxue Tongluo decoctionon early and medium stage of diabetic nephropathy[J].,2019,(1):1390.
[4]玉山江·艾克木,哈丽达·木沙△,地丽尼嘎尔.西红康联合还原型谷胱甘肽治疗2型糖尿病肾病Ⅲ期气阴两虚夹瘀证疗效及对患者微炎症状态、抗氧化的影响*[J].陕西中医,2020,(3):338.
　Yushanjiang·Aikemu,Halida·Musha,Dilinigaer..Efficacy of adjuvant therapy of Xihongkang on type 2 diabetic nephropathy Ⅲ phase with syndrome of Qiyin Liangxu Jiayu type and its effect on micro inflammation and antioxidant role[J].,2020,(1):338.
[5]马民凯,马红建,陈新苗.通络散结汤对3期糖尿病肾病患者GFR、UAER、β2-MG、Cys-C及微炎症状态的影响*[J].陕西中医,2020,(10):1432.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.025]
[6]田娟娟,陈 强,周欣欣,等.益气养阴活血法治疗糖尿病肾病理论探究*[J].陕西中医,2020,(12):1781.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.026]
[7]代广玉,修丽梅.糖尿病肾病中医辨证分型研究进展[J].陕西中医,2021,(1):131.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.036]
[8]赵 亚,张勉之,樊威伟,等.国医大师张大宁治疗糖尿病肾病用药经验[J].陕西中医,2021,(6):773.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.025]
[9]张 蕊,王子承,蒋荣莉,等.防己黄芪汤加味治疗糖尿病肾病疗效及对患者糖脂代谢、氧化应激的影响[J].陕西中医,2021,(8):1049.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.015]
　ZHANG Rui,WANG Zicheng,JIANG Rongli,et al.Effect of Fangji Huangqi decoction on diabetic nephropathy and its influence on glucose and lipid metabolism and oxidative stress[J].,2021,(1):1049.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.015]
[10]方锦颖,王一冲,神原优滋(日本),等.基于网络药理学和分子对接探究肾康注射液治疗糖尿病肾病作用机制[J].陕西中医,2021,(12):1798.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.039]

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局项目(2022544)
更新日期/Last Update: 2025-01-09